This content is machine translated Psoriasis vulgaris Practice-oriented recommendations for system therapy Fortunately, developments in recent years have led to the effective treatment of many patients with moderate to severe psoriasis. In addition to classical immunosuppressants, several biologics and a small molecule…
View Post 5 min This content is machine translated Update EULAR treatment recommendations Carefully consider the use of JAK inhibitors The goal of rheumatoid arthritis (RA) therapy today is clinical remission. The earlier the disease is detected, the better the chances of achieving this goal. For the road ahead, EULAR…
This content is machine translated Rheumatoid arthritis in elderly patients Evidence-based therapy selection under the aspect of benefits and risks Current evidence suggests that the benefits of low-dose steroid therapy are greater than the harms in elderly patients with rheumatoid arthritis (RA). This is evident from the GLORIA study, in…
View Post 12 min This content is machine translated Axial spondyloarthritis and psoriatic arthritis Effective and efficient against pain The anti-IL-17A monoclonal antibody ixekizumab has already been approved since 2016 for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis. In 2020, axial spondyloarthritis (axSpA) was added… CME-Test
View Post 5 min This content is machine translated Rheumatoid arthritis Halting joint destruction through early use of DMARDs Early adequate therapy of rheumatoid arthritis (RA) is of central importance for the entire further course of the disease, current guidelines conclude. After diagnosis, the indication for disease-modifying therapy should…
View Post 5 min This content is machine translated Gerontorheumatology Interaction risks: Cave polypharmacy! In elderly and very old patients with rheumatic and musculoskeletal diseases, multimorbidity and polypharmacy in particular require careful consideration with regard to possible interaction effects.
View Post 6 min This content is machine translated Annual Swiss Psoriasis Day Thematic aspects of psoriasis in a new light At the Annual Swiss Psoriasis Day in Basel, the benefits of international and national psoriasis registries were discussed. Furthermore, the possibility of therapy optimization in severe and moderate plaque psoriasis…
View Post 5 min This content is machine translated Apremilast PDE4 inhibition in the treatment of inflammatory diseases. The PDE-4 inhibitor apremilast was discussed as a potential option in the treatment of psoriatic arthritis at this year’s ACR Congress in San Diego. Promising results show good efficacy both…
View Post 3 min This content is machine translated Psoriatic Arthritis Therapeutic options and results There are increasing signs of success in the treatment not only of rheumatoid arthritis (RA), but also of psoriatic arthritis (PsA). At the ACR Congress in San Diego, researchers were…
View Post 5 min This content is machine translated Rheumatoid arthritis What extended benefits do currently used medications provide? Rheumatoid arthritis (RA) is a chronic disease that causes swelling and, consequently, restricted movement and joint pain. It is twice as common in women as in men, and the incidence…
View Post 4 min This content is machine translated Rheumatoid arthritis New guidelines for treatment and risk stratification In presenting the new recommendations in the management of rheumatoid arthritis, speakers at this year’s EULAR addressed the role of combined triple therapy with conventional DMARDs among other topics. Their…
